Physician profile
John L King
NPI 1467451237
$23,841.74
in general payments reported to CMS, 2019-2025
11 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,094 · 2020: $349 · 2021: $4,448 · 2022: $5,256 · 2023: $4,172 · 2024: $6,880 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $3,200 · Travel and Lodging: $2,944 · Consulting Fee: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $3,199.62 |
| Travel and Lodging | $2,944.35 |
| Consulting Fee | $1,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $12,534.58 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $9,754.65 | 2019-2025 | Da Vinci Surgical System |
| Kerecis Limited | $381.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Davol INC. | $307.62 | 2020-2023 | Arista Ah Flexitip |
| Intra-Sana Laboratories | $284.72 | 2024-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Distalmotion US | $262.66 | 2024 | Dexter L6 Robot |
| Pacira Pharmaceuticals Incorporated | $152.88 | 2020 | |
| Teleflex LLC | $84.54 | 2025 | Deknatel |
| Nestle Healthcare Nutrition INC. | $35.93 | 2021 | |
| Tas Medical, INC. | $26.72 | 2024 | |
| Heron Therapeutics, INC. | $15.46 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.